Clinical trial
Safety and Efficacy Investigation of Patients With Ischemic Cardiomyopathy by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells
NCT01946048 is registered in ClinicalTrials.gov with Hebei Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy Investigation of Patients With Ischemic Cardiomyopathy by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells
- Lead sponsor
- Hebei Medical University
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- October 31, 2013
- Completion date
- December 31, 2014
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ischemic cardiomyopathy